At a glance
ClinicalIndex Comparison RecordN/ACompleted· 25 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of the Effectiveness of Prophylactic Low Molecular Weight Heparin by Thromboelastography in Patients Who Underwent Lobectomy Due to Malignancy
In Brief
An observational study for Malignancy. Completed, enrolled 25 participants across 1 site.
Detailed Summary
This study aims to evaluate the necessity and effectiveness of using low molecular weight heparin (LMWH) for prophylaxis in the postoperative period in patients who underwent lobectomy due to malignancy, using thromboelastography.Blood samples taken from the patients before low molecular weight heparin prophylaxis (preoperative), before prophylaxis in the postoperative period (postoperative day 1) and after the start of postoperative prophylaxis (postoperative day 3) will be examined by thromboelastography.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsMalignancy
CountriesTurkey (Türkiye)
Collaborators--
Timeline
N/ACompletedFinished
202420252026
Enrollment StartJul 2023
First PostedJul 2024
Primary CompletionAug 2025
TodayJul 2026
First PostedJul 3, 2024
Enrollment StartJul 24, 2023
Primary CompletionAug 6, 2025
TodayJul 2, 2026
Enrollment to primary: 2.0 yearsPosted 2.0 years ago